Interdisciplinary Consensus Statement on Indication and Application of a Hydrogel Spacer for Prostate Radiotherapy Based on Experience in More Than 250 Patients

Overview

Journal Radiol Oncol

Publisher Sciendo

Specialties Oncology
Radiology

Date 2016 Sep 29

PMID 27679550

Citations 12

Authors

Arndt-Christian Muller

Johannes Mischinger

Theodor Klotz

Bernd Gagel

Gregor Habl

Gencay Hatiboglu

Michael Pinkawa

Affiliations

Soon will be listed here.

Abstract

Background: The aim of the study was to reach a consensus on indication and application of a hydrogel spacer based on multicentre experience and give new users important information to shorten the learning curve for this innovative technique.

Methods: The interdisciplinary meeting was attended by radiation oncologists and urologists, each with experience of 23 - 138 hydrogel injections (SpaceOAR®) in prostate cancer patients before dose-escalated radiotherapy. User experience was discussed and questions were defined to comprise practical information relevant for successful hydrogel injection and treatment. Answers to the defined key questions were generated. Hydrogel-associated side effects were collected to estimate the percentage, treatment and prognosis of potential risks.

Results: The main indication for hydrogel application was dose-escalated radiotherapy for histologically confirmed low or intermediate risk prostate cancer. It was not recommended in locally advanced prostate cancer. The injection or implantation was performed under transrectal ultrasound guidance via the transperineal approach after prior hydrodissection. The rate of injection-related G2-toxicity was 2% (n = 5) in a total of 258 hydrogel applications. The most frequent complication (n = 4) was rectal wall penetration, diagnosed at different intervals after hydrogel injection and treated conservatively.

Conclusions: A consensus was reached on the application of a hydrogel spacer. Current experience demonstrated feasibility, which could promote initiation of this method in more centres to reduce radiation-related gastrointestinal toxicity of dose-escalated IGRT. However, a very low rate of a potential serious adverse event could not be excluded. Therefore, the application should carefully be discussed with the patient and be balanced against potential benefits.

Citing Articles

XIOSIS: An X-Ray-Based Intra-Operative Image-Guided Platform for Oncology Smart Material Delivery.

Hooshangnejad H, China D, Huang Y, Zbijewski W, Uneri A, McNutt T IEEE Trans Med Imaging. 2024; 43(9):3176-3187.

PMID: 38602853 PMC: 11418373. DOI: 10.1109/TMI.2024.3387830.

Application of Hydrogel Spacer SpaceOAR Vue for Prostate Radiotherapy.

Hadigal S, Gupta A Tomography. 2022; 8(6):2648-2661.

PMID: 36412680 PMC: 9680261. DOI: 10.3390/tomography8060221.

Comprehensive review of the use of hydrogel spacers prior to radiation therapy for prostate cancer.

Harvey M, Ong W, Chao M, Udovicich C, McBride S, Bolton D BJU Int. 2022; 131(3):280-287.

PMID: 35689413 PMC: 9734283. DOI: 10.1111/bju.15821.

Finite Element-Based Personalized Simulation of Duodenal Hydrogel Spacer: Spacer Location Dependent Duodenal Sparing and a Decision Support System for Spacer-Enabled Pancreatic Cancer Radiation Therapy.

Hooshangnejad H, Youssefian S, Narang A, Shin E, Rao A, Han-Oh S Front Oncol. 2022; 12:833231.

PMID: 35402281 PMC: 8987290. DOI: 10.3389/fonc.2022.833231.

Demonstrating the benefits of corrective intraoperative feedback in improving the quality of duodenal hydrogel spacer placement.

Hooshangnejad H, Han-Oh S, Shin E, Narang A, Rao A, Lee J Med Phys. 2022; 49(7):4794-4803.

PMID: 35394064 PMC: 9540875. DOI: 10.1002/mp.15665.

References

Nguyen P, Devlin P, Beard C, Orio 3rd P, OLeary M, Wolfsberger L . High-dose-rate brachytherapy for prostate cancer in a previously radiated patient with polyethylene glycol hydrogel spacing to reduce rectal dose: case report and review of the literature. Brachytherapy. 2012; 12(1):77-83. DOI: 10.1016/j.brachy.2012.03.005. View

Arcangeli S, Agolli L, Donato V . Retreatment for prostate cancer with stereotactic body radiation therapy (SBRT): Feasible or foolhardy?. Rep Pract Oncol Radiother. 2015; 20(6):425-9. PMC: 4661353. DOI: 10.1016/j.rpor.2014.08.001. View

Song D, Herfarth K, Uhl M, Eble M, Pinkawa M, van Triest B . A multi-institutional clinical trial of rectal dose reduction via injected polyethylene-glycol hydrogel during intensity modulated radiation therapy for prostate cancer: analysis of dosimetric outcomes. Int J Radiat Oncol Biol Phys. 2013; 87(1):81-7. PMC: 3737267. DOI: 10.1016/j.ijrobp.2012.12.019. View

Ng M, Brown E, Williams A, Chao M, Lawrentschuk N, Chee R . Fiducial markers and spacers in prostate radiotherapy: current applications. BJU Int. 2014; 113 Suppl 2:13-20. DOI: 10.1111/bju.12624. View

Hatiboglu G, Pinkawa M, Vallee J, Hadaschik B, Hohenfellner M . Application technique: placement of a prostate-rectum spacer in men undergoing prostate radiation therapy. BJU Int. 2012; 110(11 Pt B):E647-52. DOI: 10.1111/j.1464-410X.2012.11373.x. View

Viswanathan A, Damato A, Nguyen P . Novel use of a hydrogel spacer permits reirradiation in otherwise incurable recurrent gynecologic cancers. J Clin Oncol. 2013; 31(34):e446-7. PMC: 5795666. DOI: 10.1200/JCO.2012.47.9931. View

Zietman A, Bae K, Slater J, Shipley W, Efstathiou J, Coen J . Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: long-term results from proton radiation oncology group/american college of radiology 95-09. J Clin Oncol. 2010; 28(7):1106-11. PMC: 2834463. DOI: 10.1200/JCO.2009.25.8475. View

Pinkawa M, Piroth M, Holy R, Escobar-Corral N, Caffaro M, Djukic V . Quality of life after intensity-modulated radiotherapy for prostate cancer with a hydrogel spacer. Matched-pair analysis. Strahlenther Onkol. 2012; 188(10):917-25. DOI: 10.1007/s00066-012-0172-6. View

Dearnaley D, Syndikus I, Sumo G, Bidmead M, Bloomfield D, Clark C . Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: preliminary safety results from the CHHiP randomised controlled trial. Lancet Oncol. 2011; 13(1):43-54. DOI: 10.1016/S1470-2045(11)70293-5. View

10.

Bachmann R, Heinzelmann F, Muller A, Ladurner R, Schneider C, Konigsrainer A . Laparoscopic pelvic mesh placement with closure of pelvic floor entrance to prevent small intestine radiation trauma - A retrospective cohort analysis. Int J Surg. 2015; 23(Pt A):62-7. DOI: 10.1016/j.ijsu.2015.08.082. View

11.

Wolf F, Gaisberger C, Ziegler I, Krenn E, Scherer P, Hruby S . Comparison of two different rectal spacers in prostate cancer external beam radiotherapy in terms of rectal sparing and volume consistency. Radiother Oncol. 2015; 116(2):221-5. DOI: 10.1016/j.radonc.2015.07.027. View

12.

Christodouleas J, Tang S, Susil R, McNutt T, Song D, Bekelman J . The effect of anterior proton beams in the setting of a prostate-rectum spacer. Med Dosim. 2013; 38(3):315-9. PMC: 3968918. DOI: 10.1016/j.meddos.2013.03.002. View

13.

Eckert F, Alloussi S, Paulsen F, Bamberg M, Zips D, Spillner P . Prospective evaluation of a hydrogel spacer for rectal separation in dose-escalated intensity-modulated radiotherapy for clinically localized prostate cancer. BMC Cancer. 2013; 13:27. PMC: 3558402. DOI: 10.1186/1471-2407-13-27. View

14.

Pinkawa M, Holy R, Piroth M, Fischedick K, Schaar S, Szekely-Orban D . Consequential late effects after radiotherapy for prostate cancer - a prospective longitudinal quality of life study. Radiat Oncol. 2010; 5:27. PMC: 2857853. DOI: 10.1186/1748-717X-5-27. View

15.

Lawton C, Michalski J, El-Naqa I, Buyyounouski M, Lee W, Menard C . RTOG GU Radiation oncology specialists reach consensus on pelvic lymph node volumes for high-risk prostate cancer. Int J Radiat Oncol Biol Phys. 2008; 74(2):383-7. PMC: 2905150. DOI: 10.1016/j.ijrobp.2008.08.002. View

16.

Pinkawa M, Klotz J, Djukic V, Schubert C, Escobar-Corral N, Caffaro M . Learning curve in the application of a hydrogel spacer to protect the rectal wall during radiotherapy of localized prostate cancer. Urology. 2013; 82(4):963-8. DOI: 10.1016/j.urology.2013.07.014. View

17.

Kishi K, Iida T, Ojima T, Sonomura T, Shirai S, Nakai M . Esophageal gel-shifting technique facilitating eradicative boost or reirradiation to upper mediastinal targets of recurrent nerve lymph node without damaging esophagus. J Radiat Res. 2013; 54(4):748-54. PMC: 3709665. DOI: 10.1093/jrr/rrs137. View

18.

Villers A, McNeal J, Freiha F, Boccon-Gibod L, Stamey T . Invasion of Denonvilliers' fascia in radical prostatectomy specimens. J Urol. 1993; 149(4):793-8. DOI: 10.1016/s0022-5347(17)36209-2. View

19.

Uhl M, van Triest B, Eble M, Weber D, Herfarth K, De Weese T . Low rectal toxicity after dose escalated IMRT treatment of prostate cancer using an absorbable hydrogel for increasing and maintaining space between the rectum and prostate: results of a multi-institutional phase II trial. Radiother Oncol. 2013; 106(2):215-9. DOI: 10.1016/j.radonc.2012.11.009. View

20.

Mariados N, Sylvester J, Shah D, Karsh L, Hudes R, Beyer D . Hydrogel Spacer Prospective Multicenter Randomized Controlled Pivotal Trial: Dosimetric and Clinical Effects of Perirectal Spacer Application in Men Undergoing Prostate Image Guided Intensity Modulated Radiation Therapy. Int J Radiat Oncol Biol Phys. 2015; 92(5):971-977. DOI: 10.1016/j.ijrobp.2015.04.030. View